Jue-Ping Feng
Overview
Explore the profile of Jue-Ping Feng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feng J, Zhu R, Jiang F, Xie J, Gao C, Li M, et al.
Biomater Sci
. 2020 Oct;
8(21):6100.
PMID: 33000784
Correction for 'Melittin-encapsulating peptide hydrogels for enhanced delivery of impermeable anticancer peptides' by Jue-Ping Feng et al., Biomater. Sci., 2020, 8, 4559-4569, DOI: .
2.
Feng J, Zhu R, Jiang F, Xie J, Gao C, Li M, et al.
Biomater Sci
. 2020 Jul;
8(16):4559-4569.
PMID: 32672773
Anticancer peptides (ACPs) have gained significant attention in the past few years. Most ACPs only act toward intracellular targets. However, their low membrane penetrability often limits their anticancer efficacy. Here...
3.
Jin H, Wan C, Zou Z, Zhao G, Zhang L, Geng Y, et al.
ACS Nano
. 2018 Mar;
12(4):3295-3310.
PMID: 29558107
Immunosuppressive tumor microenvironments (TMEs) create tremendous obstacles for an effective cancer therapy. Herein, we developed a melittin-RADA hybrid peptide hydrogel loaded with doxorubicin (DOX) for a potent chemoimmunotherapy against melanoma...
4.
Gao C, Li M, Jiang A, Sun R, Jin H, Gui H, et al.
Oncol Lett
. 2018 Mar;
15(4):5451-5458.
PMID: 29552185
Tumor necrosis factor receptor-associated protein-1 (TRAP-1), a mitochondrial chaperone, contributes significantly to the progression of cancer. However, the understanding of its involvement in the clinicopathological characteristics and prognosis of colorectal...
5.
Xu R, Shen L, Wang K, Wu G, Shi C, Ding K, et al.
Chin J Cancer
. 2017 Dec;
36(1):97.
PMID: 29273089
Background: Metastatic colorectal cancer (mCRC) patients with progressive disease after all available standard therapies need new medication for further treatment. Famitinib is a small-molecule multikinase inhibitor, with promising anticancer activities....
6.
Jin H, Zhao G, Hu J, Ren Q, Yang K, Wan C, et al.
ACS Appl Mater Interfaces
. 2017 Jul;
9(31):25755-25766.
PMID: 28714303
The design of biocompatible and efficacious anticancer biomaterials to achieve relatively low tumor recurrence rates is the main pursuit of cancer photothermal therapy (PTT). RADA16-I is a synthetic amphiphilic peptide...
7.
Gao C, Sun R, Xie Y, Jiang A, Lin M, Li M, et al.
Exp Biol Med (Maywood)
. 2017 May;
242(10):1034-1043.
PMID: 28492347
Vglycin, a novel natural polypeptide isolated from pea seeds, possesses antidiabetic properties. Our previous studies have shown that Vglycin can induce the differentiation of human colon adenocarcinoma cells. We aimed...
8.
Zheng J, Lin M, Imamura F, Cai W, Wang L, Feng J, et al.
Sci Rep
. 2016 Jul;
6:29522.
PMID: 27404516
We aimed to investigate the change of serum metabolomics in response to n-3 fatty acid supplements in Chinese patients with type 2 diabetes (T2D). In a double-blind parallel randomised controlled...
9.
Sun R, Liu J, Gao C, Xiong Y, Li M, Wang Y, et al.
Oncotarget
. 2016 Apr;
7(20):29770-9.
PMID: 27105501
Increasing amounts of evidence has demonstrated that T2DM (Type 2 Diabetes Mellitus) patients have increased susceptibility to CRC (colorectal cancer). As HHEX is a recognized susceptibility gene in T2DM, this...
10.
Huang C, Feng J, Yang X, Li Y
J Surg Oncol
. 2013 Dec;
109(7):730-9.
PMID: 24374987
Background: Advanced colorectal cancer (CRC) is prone to developing peritoneal carcinomatosis (PC). This case-control study was to compare the efficacy and safety of cytoreductive surgery (CRS) versus CRS plus hyperthermic...